Exhaustive reviews in the literature (6–9) have revealed that (1) CRP levels above 10 μg/ml are indicative of an ongoing tissue damaging inflammatory response in a patient; (2) CRP levels progressively increasing from 10 μg/ml to more than 100 μg/ml are indicative of progressively more active inflammation and disease progression; (3) CRP levels above 100 μg/ml are prognostic of a poor outcome and/or a failure to respond to therapy; (4) CRP and other inflammatory markers are not useful tools to diagnose the presence of cancer. Here, CRP is linked to cancer.